Specific A10 Dopaminergic Nuclei in the Midbrain Degenerate in Parkinson's Disease
- 1 March 1997
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 144 (1) , 202-213
- https://doi.org/10.1006/exnr.1997.6418
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primatesPublished by Elsevier ,2003
- Methods for determining numbers of cells and synapses: A case for more uniform standards of reviewJournal of Comparative Neurology, 1996
- Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Loss of non-phosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment CentersNeurology, 1992
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's diseaseAnnals of Neurology, 1991
- Telencephalic Projections of the A8 Dopamine Cell GroupAnnals of the New York Academy of Sciences, 1988
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973